Autologous dendritic cells pulsed with hepatitis B virus antigens(Jiangsu Antae)

N/A

Report date: 2022/11/01 17:36:32

Base Information

Drug NameAutologous dendritic cells pulsed with hepatitis B virus antigens(Jiangsu Antae)
Drug Alias NameHepatitis B vaccine(Jiangsu Antae)Liver Cancer Vaccine (Jiangsu Antae)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Antai Biotechnology Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Antai Biotechnology Company Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A